Dizziness

From our list of herbs and spices, the following are recommended for Dizziness:

  • Ginger
  • Ginkgo Biloba
  • White Oak Bark

Natural Cures and Remedies for Dizziness

Contraindications, Interactions, and Side Effects (Aga) — Signs of intoxication include confusion, cramps, dizziness, enteralgia, mania, psychostimulation, then sedation vomiting (PH2).

Contraindications, Interactions, and Side Effects (Reishi) — Class 1. After 3–6 months consumption, rare individuals report bloody stools. Dizziness, dryness of mouth, throat and nasal area, epistaxis, itchiness, stomach upset (after using for 3–6 months) (AHP; SKY). Do not mix with other antiaggregants (SKY). Pregnant and lactating women should take only on advice of health practitioner (SKY). Rarely used with children, yet of low toxicity (WAM). May cause allergy (APA).

Catnip, Ginger Root, Licorice Root, Peppermint Leaf, Pumpkin Seed, Rehmannia Root, Valerian Root

Here I see the oft-repeated anomaly, a low dose may have the opposite effect (tachycardic) of high doses (bradycardic). Sparteine is more quinidine-like than digitalic, a powerful oxytocic once used to stimulate uterine constrictions (CAN). Sparteine sulphate can produce respiratory arrest (CAN). Sparteine is a negative chronotropic and a negative inotropic. Doses corresponding to >300 mg sparteine (ca. 30 g herb). May induce dizziness, headache, ocular palsy, palpitations, prickly sensations in the extremities, profuse sweating, sleepiness, and weakness of the legs.

symptoms from ingesting pennyroyal-containing preparations include lethargy, agitation, dizziness, sometimes leading to seizures and auditory and visual hallucinations. GI effects include nausea, vomiting, burning in the throat, abdominal pain, and diarrhea (AEH1).

WAM); Cystosis (f; MAD; PH2); Debility (f; CRC; MAB); Depression (1; APA; BGB); Dermatosis (f; CRC; MAB; MAD); Despondency (f; MAB); Dizziness (1; APA; MAB; MAD); Dys-

Contraindications, Interactions, and Side Effects (Kava) — Class 2b, 2c, 2d. Contraindicated for endogenous depression (AHP). Maximum tolerated doses for dogs was 60 mg/kg, for rats 320 mg/kg StX (70% kavapyrones). Perversely, if the authors didn’t misspeak, the dogs tolerated 24 mg/kg/day. Of >4000 patients taking 105 mg/day StX (70% kavapyrones), 1.5% had objectionable side effects (allergy, dizziness, GI distress, and headache). At levels 100 times the therapeutic dose (roughly 13 liters kava beverage a day or 300–400 mg rhizome per week) caused anorexia, ataxia, dyspnea, hair loss, red eyes, skin rash, visual problems, and yellow skin. ‘There is no potential for physical or psychological dependency. Use should not exceed 3 months.” (AHP) Germans limit use to 1–3 months (AHP). Commission E reports contraindications: esophageal and gastrointestinal stenoses; adverse effects: allergic reactions (rarely). Other sources report intestinal obstruction (AEH). Many reports suggest a yellowing of the skin in chronic users. ‘Chronic ingestion may lead to ‘kawism’ characterized by dry, flaking, discolored skin, and reddened eyes” ( LRNP, May 1987). Persistent rumors suggest that overdoses can cause intoxication. Commission E warns against the concomitant use of kava with barbituates, antidepressant medications, and CNS agents. Lactating or pregnant women should not use kava (WAM). ‘Not permitted as a non-medicinal ingredient in oral use products in Canada” (Michols, 1995). Abuse by Australian Aborigines suggest links to hematuria, infectious disease, neurological abnormalities, pulmonary hypotension, nephrosis, visual disturbances, ischemic heart disease, thrombosis, and sudden heart attacks (MAB). The following quote might scare abusers, as it should, ‘Full consciousness is maintained with even fatal doses” (APA, quoting Weiss, 1988).